Optimal settings and clinical validation for automated Ki67 calculation in neuroendocrine tumors with open source informatics (QuPath)

Optimal settings and clinical validation for automated Ki67 calculation in neuroendocrine tumors with open source informatics (QuPath)

Bibliographic Details
Main Authors:	Rima Pai, Susan Karki, Rakhee Agarwal, Steven Sieber, Samuel Barasch
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Journal of Pathology Informatics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2153353922007350

Similar Items

Digital image analysis of immunohistochemistry KI-67 using QuPath software in breast cancer
by: Hermin Aminah Usman, et al.
Published: (2021-04-01)

QuPath digital immunohistochemical analysis of placental tissue
by: Ashley L Hein, et al.
Published: (2021-01-01)

Open and reusable deep learning for pathology with WSInfer and QuPath
by: Jakub R. Kaczmarzyk, et al.
Published: (2024-01-01)

Whole-Slide Image Analysis of Human Pancreas Samples to Elucidate the Immunopathogenesis of Type 1 Diabetes Using the QuPath Software
by: Paola S. Apaolaza, et al.
Published: (2021-06-01)

QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray
by: Ross J. Porter, et al.
Published: (2023-05-01)

Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors
by: Hai-Yue Wang, et al.
Published: (2019-03-01)

Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing
by: Andreas H. Scheel, et al.
Published: (2023-10-01)

Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung
by: Rashi GARG, et al.
Published: (2019-01-01)

piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
by: Rokshana Stephny Geread, et al.
Published: (2020-12-01)

Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?
by: Ana Karina Patane, et al.
Published: (2021-01-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
by: Gasperetti F, et al.
Published: (2011-03-01)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
by: Ceren Boyaci, et al.
Published: (2021-10-01)

Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.
by: Jamali, M, et al.
Published: (2008)

Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades
by: Michele Simbolo, et al.
Published: (2021-04-01)

Risk factors and prediction model for elevated ki-67 index in pituitary neuroendocrine tumors
by: ZHANG Yuling, et al.
Published: (2023-01-01)

Computer-assisted tumor grading, validation of PD-L1 scoring, and quantification of CD8-positive immune cell density in urothelial carcinoma, a visual guide for pathologists using QuPath
by: Aline Rodrigues, et al.
Published: (2022-06-01)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2015)

The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors
by: YongYan Cui, et al.
Published: (2020-03-01)

Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning.
by: Muhammad Khalid Khan Niazi, et al.
Published: (2018-01-01)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.
by: Francesco Panzuto, et al.
Published: (2017-01-01)

Association of Ki67 Antigen With Mitotic Count, Tumor Size, and Necrosis in Neuroendocrine Tumors of Lung
by: Monireh Halimi, et al.
Published: (2020-07-01)

The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)
by: Yongkang Liu, et al.
Published: (2023-12-01)

Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study
by: Huiying Shi, et al.
Published: (2018-07-01)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
by: Francesca Di Rosa, et al.
Published: (2021-04-01)

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
by: B C M Hermans, et al.
Published: (2019-12-01)

Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis
by: Bohyun Kim, et al.
Published: (2019-02-01)

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
by: Pascale Mariarosa, et al.
Published: (2016-09-01)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
by: Francesca Di Rosa, et al.
Published: (2021-09-01)

New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas.
by: Wielisław Papierz, et al.
Published: (2010-05-01)

The intrinsically disorderly story of Ki-67
by: Lucy Remnant, et al.
Published: (2021-08-01)

Use of Novel Open-Source Deep Learning Platform for Quantification of Ki-67 in Neuroendocrine Tumors – Analytical Validation
by: Zehra T, et al.
Published: (2023-12-01)

Predictive value of morphological features and proliferative markers (mitotic index, Ki-67, PHH3) in bronchopulmonary neuroendocrine tumors
by: L. M. Zakhartseva, et al.
Published: (2021-12-01)

A semi-automated microscopic image analysis method for scoring Ki-67 nuclear immunostaining
by: S.M. Fernezlian, et al.
Published: (2023-11-01)

Automated Quantification of Ki-67 on Gastric Epithelial Tissue based on Cell Nuclei Area Ratio
by: Austin Blanco-Solano, et al.
Published: (2022-03-01)

The expression of Ki-67 marker in the hydatidiform mole
by: Ecaterina Carpenco, et al.
Published: (2022-12-01)

Role of Ki-67 in the Grading of Mucoepidermoid Carcinomas
by: Sobia Siddique
Published: (2015-06-01)

Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer.
by: Jing Ping Yuan, et al.
Published: (2015-01-01)

Diagnostic Accuracy of ki-67 Labeling Index in Endoscopic Ultrasonography-Fine-Needle Aspiration Cytology and Biopsy of Pancreatic Neuroendocrine Neoplasms
by: Jung-Soo Pyo, et al.
Published: (2023-08-01)

Ki67 and p53 in gastrointestinal stromal tumors - GIST Ki67 and p53 em tumores estromais gastrointestinais - GIST
by: Lúcio Roberto de Oliveira das Neves, et al.
Published: (2009-06-01)

Roles of Ki67 in Breast Cancer - Important for Management?
by: Yip, C.H., et al.
Published: (2016)